Xarelto Bleeding Lawsuits See Second Bellwether Trial Scheduled To Start May 30

   

Xarelto Bleeding Lawsuits Allege The Blood Thinner Causes Uncontrollable Bleeding and Has No Antidote To Reverse The Adverse Bleeding Events

xarelto-lawsuit-side-effects-lawyerAs thousands of federal Xarelto bleeding lawsuits move forward in pretrial proceedings, a second bellwether trial for a Xarelto side-effects complaints is scheduled to begin on May 30. The case will go to trial in the Eastern District of Louisiana where 16,600 Xarelto lawsuits are pending in a multidistrict litigation (MDL). Plaintiffs allege the blood thinner causes severe internal bleeding, gastrointestinal bleeding, bleeding in the brain, and other life-threatening bleeding injuries. (In Re: Xarelto Products Liability Litigation, Xarelto bleeding lawsuit No. 2592)

The Xarelto lawsuits accuse Bayer HealthCare AG which manufactures Xarelto, and Johnson & Johnson’s Janssen Pharmaceuticals Inc., which markets the blood thinner, of failing to adequately warn of the bleeding risk associated with Xarelto. The complaints further claim Xarelto does not have an antidote to reverse the medication’s anti-clotting effects.

“Without an approved reversal agent, physicians, emergency room doctors, and surgeons must develop a reversal strategy when bleeding occurs in patients taking Xarelto,” according to Dr. François Blaudeau, the founder of Southern Med Law.

The Xarelto attorneys at Southern Med Law have spoken with numerous men and women nationwide who developed life-threatening bleeding events after taking Xarelto. If you or a loved one experienced serious internal bleeding or other complications allegedly associated with Xarelto, please contact Southern Med Law to learn more about your legal rights. You can arrange for a free, no-obligation Xarelto lawsuit evaluation by calling Southern Med Law today, at 205-547-5525 or visit www.southernmedlaw.com for more information and to fill out a contact form.

The second bellwether case was filed on behalf of a Louisiana man whose wife died from a brain bleed about a month after she began taking Xarelto. The complaint accuses the defendants of failing to warn that Xarelto does not have an antidote should significant bleeding episodes occur in patients taking the blood thinner. (Case No. 2:15-cv-03708, In Re: Xarelto Products Liability Litigation, No. 2592) Bellwether trials are considered “test trials” that help plaintiffs, defendants and the court determine the outcome of future trials or consider the possibility of settling other lawsuits pending in the litigation.

Xarelto (rivaroxaban) is approved by the U.S. Food and Drug Administration (FDA) to prevent strokes, deep vein thrombosis, pulmonary embolism, and blood clots in patients with atrial fibrillation not caused by a heart valve problem. Xarelto is a latest generation blood thinner promoted as more being convenient to use than warfarin (Coumadin, Jantoven), the oldest blood thinner on the market approved by the FDA in 1954. Xarelto does not require routine blood monitoring as does warfarin and there are no known diet restrictions as there are for patients who take warfarin. Xarelto, however, does not have an FDA-approved antidote to treat uncontrollable bleeding, whereas vitamin K is used to reverse adverse bleeding side effects caused by warfarin, according to the FDA.
[xarelto-us.com/blood-thinner/xarelto-vs-warfarin]
[fda.gov/Drugs/NewsEvents/ucm405148.htm]

In addition to the May 30 trial, bellwether trials for federal Xarelto complaints will continue over the summer. U.S. District Judge Eldon E. Fallon, who is managing the Xarelto MDL, has scheduled the third trial for June in the Southern District of Mississippi. The case involves a woman who suffered a gastrointestinal bleed allegedly after taking Xarelto. The fourth trial is set for July in the Northern District of Texas and involves a man who died from gastrointestinal bleeding that occurred allegedly after using Xarelto. (Xarelto Lawsuits Case No. 2:15-cv-03469 Case No. 2:15-cv-00224).

About Southern Med Law And Filing A Xarelto Bleeding Lawsuit

Throughout his career, Dr. Blaudeau has worked hard to develop a strong reputation in healthcare litigation. His first-hand knowledge of medicine has made the Southern Med Law team an aggressive and effective attorney and advocate for those who were harmed due to negligent pharmaceutical companies. If you or a loved one where harmed by Xarelto, please contact Southern Med Law today to learn more about your legal rights. Call today for a free, no obligation Xarelto lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.

Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: 205-547-5525
Fax: 205-547-5526
francois@southernmedlaw.com
www.southernmedlaw.com

This entry was posted in Southern Med Law | Article. Bookmark the permalink.